Yahya İSLAMOĞLU, Eyüp BÜYÜKKAYA, Zekeriya KAYA, Enbiya AKSAKAL, Kamuran KALKAN, Necdet ÖZAYDOĞDU, Sümen SÜMBÜL, Serdar SOYDİŞ

İnfektif endokarditin klinik sonuçları üzerine hematolojik ve biyokimyasal parametrelerin etkisi

Amaç: Çalışmamızda İnfektif endokarditli (İE) hastalarda hematolojik parametrelerdeki değişiklikleri ve bu değişikliklerin komplikasyon ve mortalite oranları ile ilişkisini araştırmayı amaçladık. Gereç ve yöntem: Dicle Üniversitesi, Atatürk Üniversitesi ve Harran Üniversitesi Tıp Fakültelerinin kardiyoloji bölümlerinde İE tanısı ile Haziran 2007 den Haziran 2011 tarihleri arasında yatırılan 44 hasta retrospektif olarak değerlendirildi. İE tanısında Duke kriterleri esas alındı. Hematolojik ve biyokimyasal parametreler kaydedildi. Bulgular: Yaşayan hastalar ile karşılaştırıldığında, İE bağlı ölen hastalarda ortalama yaş, beyaz küre sayısı, nötrofil sayısı, ortalama trombosit hacmi ve komplikasyon oranı daha yüksek bulundu (sırasıyla, p

Effect of the hematological and biochemical parameters on outcomes of the patients with infective endocarditis

Objectives: This study was designed to examine haematological changes in infective endocarditis (IE) and the association between laboratory findings and mortality or complications including events in IE. Materials and methods: Forty-four patients who were hospitalized with a diagnosis of IE at the Department of Cardiology, Dicle University, Ataturk University and Harran University, from June 2007 to June 2011, were retrospectively evaluated. The diagnosis of IE was made clinically and was confi rmed with Duke’s criteria. The haematological and biochemical parameters were recorded. Results: Age, white blood cell count, neutrophil count, neutrophil lymphocyte ratio, mean platelet volume and complication rate (p <0.004, p <0.05, p <0.03, p <0.05, p <0.01, p <0.004, respectively) were elevated in patients who died due to infective endocarditis compared with patients who survived. However, platelet count were lower in patients died (p <0.05). Additionally, patients who developed complications were no difference laboratory findings compared with patients without complications. Conclusion: Age, MPV and presence of complications can be used as risk factors for mortality in IE. In addition, S.aureus is associated with complications.

PDF

___

1. Horstkotte D, Follath F, Gutschik E et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004;25(3):267-6.
2. Hellgren U, Julander I. Are white blood cell count, platelet count, erythrocyte sedimentation rate and C-reactive protein useful in the diagnosis of septicaemia and endocarditis? Scand J Infect Dis 1986 ;18(5):487-8.
3. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002;88(1):53-60.
4. Gunebakmaz O, Kaya MG, Kaya EG et al. Mean platelet volume predicts embolic complications and prognosis in infective endocarditis. Int J Infect Dis 2010;14(11):e982-5.
5. Van der Lelie J, Von dem Borne AK. Increased mean platelet volume in septicaemia. J Clin Pathol 1983 ;36(6):693-6.
6. Wangsomboonsiri W, Luksananun T, Saksornchai S, Ketwong K, Sungkanuparph S. Streptococcus suis infection and risk factors for mortality. J Infect. 2008;57(5):392-6.
7. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111(23):e394-434.
8. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30(4):633-8.
9. İnanç T, Kaya MG, Kaya EG ve ark. İnfektif endokardit: retrospektif olarak 27 hastanın değerlendirilmesi. TAD 2007;5(3):91-9.
10. Leblebicioglu H, Yilmaz H, Tasova Y et al. Characteristics and analysis of risk factors for mortality in infective endocarditis. Eur J Epidemiol 2006;21(1):25-31.
11. Yavuz SS, Eren M, Yavuz A ve ark. İnfektif Endokardit: 58 olgunun değerlendirilmesi. Klimik Dergisi 2003;16(2):55-62.
12. Whitby M, Fenech A. Infective endocarditis in adults in Glasgow, 1976-81. Int J Cardiol 1985;7(4):391-403.
13. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994 ;96(3):200-9.
14. Heiro M, Helenius H, Sundell J et al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 2005 ;26(18):1873-81.
15. Hogevik H, Olaison L, Andersson R, Alestig K. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection 1997 ;25(2):82-5.
16. Lancellotti P, Galiuto L, Albert A, Soyeur D, Pierard LA. Relative value of clinical and transesophageal echocardiographic variables for risk stratifi cation in patients with infective endocarditis. Clin Cardiol 1998 ;21(8): 572-8.
17. Ako J, Ikari Y, Hatori M, Hara K, Ouchi Y. Changing spectrum of infective endocarditis: review of 194 episodes over 20 years. Circ J 2003 ;67(1): 3-7.
18. Chu VH, Cabell CH, Benjamin DK Jr et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109(14): 1745-9.